CanSino said in a statement on April 14 that no serious blood clot cases had been reported in people inoculated with its COVID-19 vaccine. /CFP China's CanSino Biologics Inc. said on Wednesday
China has largely controlled COVID-19, and the rest of the world can still learn from China's successes in bringing its outbreak under control, according to the latest editorial by medical journal
简体中文
